Literature DB >> 33178996

The primary pulmonary NUT carcinomas and some uncommon somatic mutations identified by next-generation sequencing: a case report.

Ying Liu1, Yan-Ying Li1, Xue-Xuan Ke2, You Lu1.   

Abstract

Nuclear protein in testis (NUT) carcinoma (NUT-C) is an exceedingly rare and aggressive squamous tumor characterized by an acquired rearrangement of the NUT gene involving the NUTM1 (Nut midline carcinoma, family member 1, NUT) gene encoding the nuclear protein of the testis on 15q14. As a rare tumor, there is little information available on the clinicopathologic and molecular cytogenetic findings of NMC. We herein reported a case of a 69-year-old man diagnosed with lung NMC involving the rearrangement of chromosomal region 15q14 harboring the NUTM1 gene. It was exceptionally rare for the patient's involving of the lung but having the chance to be totally resected. After radical surgery, the patient accepted further four cycles of chemotherapy and remains disease-free after 10 months. The immunohistochemical staining of PDL1 was negative and next-generation sequencing technology identified genomic alterations in discoidin domain receptor tyrosine kinase 2 (DDR2), cyclin D1 (CCND1), B-cell leukemia/lymphoma 1 (BCL1), colony-stimulating factor 1 receptor (CSF1R), runt related transcription factor 1 (RUNX1) and death domain-associated protein 6 (DAXX6) from the paraffin-embedded tissue. This case will contribute to not only a better understanding of the molecular mechanism of the primary pulmonary NUT carcinomas but also the potential therapeutic option for the patient. 2020 AME Case Reports. All rights reserved.

Entities:  

Keywords:  NUT; NUT midline carcinoma (NMC); case report; next-generation sequencing

Year:  2020        PMID: 33178996      PMCID: PMC7608724          DOI: 10.21037/acr-19-168

Source DB:  PubMed          Journal:  AME Case Rep        ISSN: 2523-1995


  26 in total

1.  Successful treatment of a child with t(15;19)-positive tumor.

Authors:  Fredrik Mertens; Thomas Wiebe; Catharina Adlercreutz; Nils Mandahl; Christopher A French
Journal:  Pediatr Blood Cancer       Date:  2007-12       Impact factor: 3.167

2.  Runx1: no longer just for leukemia.

Authors:  Ichiro Taniuchi; Motomi Osato; Yoshiaki Ito
Journal:  EMBO J       Date:  2012-10-12       Impact factor: 11.598

3.  Clinicopathologic features and long-term outcomes of NUT midline carcinoma.

Authors:  Daniel E Bauer; Chelsey M Mitchell; Kelly M Strait; Christopher S Lathan; Edward B Stelow; Sonja C Lüer; Somala Muhammed; Andrew G Evans; Lynette M Sholl; Juan Rosai; Eugenia Giraldi; Richard P Oakley; Carlos Rodriguez-Galindo; Wendy B London; Stephen E Sallan; James E Bradner; Christopher A French
Journal:  Clin Cancer Res       Date:  2012-08-15       Impact factor: 12.531

4.  Novel t(15;19)(q15;p13) chromosome abnormality in a thymic carcinoma.

Authors:  I Kubonishi; N Takehara; J Iwata; H Sonobe; Y Ohtsuki; T Abe; I Miyoshi
Journal:  Cancer Res       Date:  1991-06-15       Impact factor: 12.701

5.  Clinical Response of Carcinomas Harboring the BRD4-NUT Oncoprotein to the Targeted Bromodomain Inhibitor OTX015/MK-8628.

Authors:  Anastasios Stathis; Emanuele Zucca; Mohamed Bekradda; Carlos Gomez-Roca; Jean-Pierre Delord; Thibault de La Motte Rouge; Emmanuelle Uro-Coste; Filippo de Braud; Giuseppe Pelosi; Christopher A French
Journal:  Cancer Discov       Date:  2016-03-14       Impact factor: 39.397

6.  Alterations in DNA Damage Response and Repair Genes as Potential Marker of Clinical Benefit From PD-1/PD-L1 Blockade in Advanced Urothelial Cancers.

Authors:  Min Yuen Teo; Kenneth Seier; Irina Ostrovnaya; Ashley M Regazzi; Brooke E Kania; Meredith M Moran; Catharine K Cipolla; Mark J Bluth; Joshua Chaim; Hikmat Al-Ahmadie; Alexandra Snyder; Maria I Carlo; David B Solit; Michael F Berger; Samuel Funt; Jedd D Wolchok; Gopa Iyer; Dean F Bajorin; Margaret K Callahan; Jonathan E Rosenberg
Journal:  J Clin Oncol       Date:  2018-02-28       Impact factor: 44.544

7.  Uncommon somatic mutations in metastatic NUT midline carcinoma.

Authors:  Stefano Cavalieri; Anastasios Stathis; Alessandra Fabbri; Angelica Sonzogni; Federica Perrone; Elena Tamborini; Giuseppe Pelosi; Filippo de Braud; Marco Platania
Journal:  Tumori       Date:  2017-11-15       Impact factor: 2.098

8.  BRD-NUT oncoproteins: a family of closely related nuclear proteins that block epithelial differentiation and maintain the growth of carcinoma cells.

Authors:  C A French; C L Ramirez; J Kolmakova; T T Hickman; M J Cameron; M E Thyne; J L Kutok; J A Toretsky; A K Tadavarthy; U R Kees; J A Fletcher; J C Aster
Journal:  Oncogene       Date:  2007-10-15       Impact factor: 9.867

9.  Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroids.

Authors:  Rosa Rademakers; Matt Baker; Alexandra M Nicholson; Nicola J Rutherford; NiCole Finch; Alexandra Soto-Ortolaza; Jennifer Lash; Christian Wider; Aleksandra Wojtas; Mariely DeJesus-Hernandez; Jennifer Adamson; Naomi Kouri; Christina Sundal; Elizabeth A Shuster; Jan Aasly; James MacKenzie; Sigrun Roeber; Hans A Kretzschmar; Bradley F Boeve; David S Knopman; Ronald C Petersen; Nigel J Cairns; Bernardino Ghetti; Salvatore Spina; James Garbern; Alexandros C Tselis; Ryan Uitti; Pritam Das; Jay A Van Gerpen; James F Meschia; Shawn Levy; Daniel F Broderick; Neill Graff-Radford; Owen A Ross; Bradley B Miller; Russell H Swerdlow; Dennis W Dickson; Zbigniew K Wszolek
Journal:  Nat Genet       Date:  2011-12-25       Impact factor: 38.330

10.  Targeting DDR2 enhances tumor response to anti-PD-1 immunotherapy.

Authors:  Megan M Tu; Francis Y F Lee; Robert T Jones; Abigail K Kimball; Elizabeth Saravia; Robert F Graziano; Brianne Coleman; Krista Menard; Jun Yan; Erin Michaud; Han Chang; Hany A Abdel-Hafiz; Andrii I Rozhok; Jason E Duex; Neeraj Agarwal; Ana Chauca-Diaz; Linda K Johnson; Terry L Ng; John C Cambier; Eric T Clambey; James C Costello; Alan J Korman; Dan Theodorescu
Journal:  Sci Adv       Date:  2019-02-20       Impact factor: 14.136

View more
  1 in total

Review 1.  Nuclear protein of the testis midline carcinoma of the thorax.

Authors:  Ayae Saiki; Keita Sakamoto; Yuan Bee; Takehiro Izumo
Journal:  Jpn J Clin Oncol       Date:  2022-05-31       Impact factor: 2.925

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.